Atlas Trials

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

Clinical trial NCT02509806 · UNKNOWN

Trial details

NCT number
NCT02509806
Sponsor
Hebei Medical University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2015-07-01
Primary completion
2017-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.